Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
MEARS E CLINICAL EXPERIENCE IN THE USE OF ORAL CONTRACEPTIVES. 1964 Proc. R. Soc. Med. pmid:14130873
Fowler AK et al. Activation of C-type RNA virus markers in mouse uterine tissue. 1972 Proc. Natl. Acad. Sci. U.S.A. pmid:4340751
Ortiz de Montellano PR et al. Self-catalyzed destruction of cytochrome P-450: covalent binding of ethynyl sterols to prosthetic heme. 1979 Proc. Natl. Acad. Sci. U.S.A. pmid:284396
Golubovskaia LE et al. [Comparative determination of norethisterone in the blood plasma by radioimmunological and chromato-mass fragmentographic methods]. 1985 Nov-Dec Probl Endokrinol (Mosk) pmid:4088995
Kreutner AK Adolescent contraception. 1987 Prim. Care pmid:3645678
Gorins A and Netter A [Contribution of the norsteroids in the treatment of advanced breast cancer]. 1969 Presse Med pmid:5806681
Rozenbaum H [A new oral contraceptive: LG 340]. 1971 Presse Med pmid:5093019
VILLAMAYOR RD et al. [MASTODYNIA AND NORSTEROIDS]. 1963 Prensa Med Argent pmid:14090064
Dysmenorrhoea unrelieved by an oral contraceptive. 1968 Practitioner pmid:4871666
Robertson MC A study of women on the progestogen only pill. 1984 Practitioner pmid:6728816
Wilson E Injectable contraception. 1988 Practitioner pmid:2975377
Howell A and Ribeiro G Management of advanced carcinoma of the breast. 1985 Practitioner pmid:3975209
BUXTON CL and KASE N HORMONAL CONTROL OF CONCEPTION. 1964 Practitioner pmid:14130829
HAWKINS DF METROPATHIA HAEMORRHAGICA. 1963 Practitioner pmid:14062176
Law B Oral contraception--choice of treatment. 1977 Practitioner pmid:594014
Cameron I Management of menorrhagia. 1992 Practitioner pmid:1454734
Dudley B Treatment of the artificial menopause. 1967 Practitioner pmid:6047166
Postlethwaite DL Pregnancy rate of a progestogen oral contraceptive. 1979 Practitioner pmid:432188
WINTERTON WR ABORTIONS AND MISCARRIAGES. 1964 Practitioner pmid:14122916
Bonduelle M et al. A comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia. 1991 Postgrad Med J pmid:1835005
Moore B Sequential mestranol and morethisterone in the treatment of the climacteric syndrome. 1976 Postgrad Med J pmid:981118
Burnett D et al. Plasma protein changes in post-menopausal women receiving mestranol-norethisterone hormone replacement therapy. 1976 Postgrad Med J pmid:981119
Aylward M Coagulation factors in opposed and unopposed oestrogen treatment at the climacteric. 1978 Postgrad Med J pmid:740578
Sturdee DW et al. Glucose tolerance and hormone replacement therapy. A preliminary study. 1976 Postgrad Med J pmid:981120
KISTNER RW STEROID COMPOUNDS WITH PROGESTATIONAL ACTIVITY. 1964 Postgrad Med pmid:14129897
Fuller ME Oral contraceptive therapy for differentiating ovarian cysts. 1971 Postgrad Med pmid:5557719
Bush M et al. Effects of multiple doses of albiglutide on the pharmacokinetics, pharmacodynamics, and safety of digoxin, warfarin, or a low-dose oral contraceptive. 2012 Postgrad Med pmid:23322139
Long-acting progestins--promise and prospects. 1983 Popul Rep K pmid:6222930
Gonzalez-Montalban N et al. Highly efficient protein misfolding cyclic amplification. 2011 PLoS Pathog. pmid:21347353
Callewaert L et al. A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria. 2008 PLoS Pathog. pmid:18369469
Leavis HL et al. Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. 2007 PLoS Pathog. pmid:17257059
Schrettl M et al. Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infection. 2007 PLoS Pathog. pmid:17845073
Robinson P et al. Substance P causes seizures in neurocysticercosis. 2012 PLoS Pathog. pmid:22346746
Chandra A et al. The anti-inflammatory and antibacterial basis of human omental defense: selective expression of cytokines and antimicrobial peptides. 2011 PLoS ONE pmid:21647223
Luk SU et al. Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. 2011 PLoS ONE pmid:21603625
Liou JW et al. Visible light responsive photocatalyst induces progressive and apical-terminus preferential damages on Escherichia coli surfaces. 2011 PLoS ONE pmid:21589873
Bock J et al. Mammalian stem cells reprogramming in response to terahertz radiation. 2010 PLoS ONE pmid:21209821
Rayavarapu S et al. Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype. 2010 PLoS ONE pmid:20886045
Balseiro P et al. Mytilus galloprovincialis myticin C: a chemotactic molecule with antiviral activity and immunoregulatory properties. 2011 PLoS ONE pmid:21858010
Medina-Navarro R et al. Protein antioxidant response to the stress and the relationship between molecular structure and antioxidant function. 2010 PLoS ONE pmid:20126468
Hasegawa S et al. Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database. 2017 PLoS ONE pmid:28732067
Gaseitsiwe S et al. Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from M. tuberculosis. 2008 PLoS ONE pmid:19065269
Tomasicchio M et al. The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor. 2013 PLoS ONE pmid:23658782
Chawla B et al. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani. 2012 PLoS ONE pmid:22438895
Govender Y et al. The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor. 2014 PLoS ONE pmid:24840644
Raju G et al. Interaction of pyrrolobenzodiazepine (PBD) ligands with parallel intermolecular G-quadruplex complex using spectroscopy and ESI-MS. 2012 PLoS ONE pmid:22558271
Vaz MC et al. Excreted thiocyanate detects live reef fishes illegally collected using cyanide--a non-invasive and non-destructive testing approach. 2012 PLoS ONE pmid:22536375
Du WG et al. Patterns of interspecific variation in the heart rates of embryonic reptiles. 2011 PLoS ONE pmid:22174948
Kleynhans L et al. Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users. 2011 PLoS ONE pmid:21931790
Das A et al. Targeting RNA by small molecules: comparative structural and thermodynamic aspects of aristololactam-β-D-glucoside and daunomycin binding to tRNA(phe). 2011 PLoS ONE pmid:21858023